Skip to results
Modify your search
NARROW
1-20 of 60
Authors: Milton Packer
Journal Article
Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1304–1317, https://doi.org/10.1093/eurheartj/ehae938
Published: 04 March 2025
Journal Article
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial
European Heart Journal, ehaf057, https://doi.org/10.1093/eurheartj/ehaf057
Published: 28 January 2025
Journal Article
Incident heart failure and recurrent coronary events following acute myocardial infarction
European Heart Journal, Volume 46, Issue 16, 21 April 2025, Pages 1540–1550, https://doi.org/10.1093/eurheartj/ehae885
Published: 28 January 2025
Journal Article
EDITOR'S CHOICE
The hypothesis: a new article type and platform for iconoclasts in medicine
European Heart Journal, Volume 46, Issue 8, 21 February 2025, Pages 685–686, https://doi.org/10.1093/eurheartj/ehae770
Published: 23 December 2024
Journal Article
Anaemia, erythrocytosis, and empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial Get access
European Heart Journal, Volume 46, Issue 11, 14 March 2025, Pages 1074–1077, https://doi.org/10.1093/eurheartj/ehae864
Published: 06 December 2024
Journal Article
Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials
European Heart Journal, Volume 45, Issue 47, 14 December 2024, Pages 5087–5099, https://doi.org/10.1093/eurheartj/ehae753
Published: 09 November 2024
Journal Article
Bladder Symptoms Provoked by Short, Rapid-Acting Loop Diuretics: A Frequent but Often Overlooked Problem Get access
American Journal of Hypertension, Volume 38, Issue 2, February 2025, Pages 100–103, https://doi.org/10.1093/ajh/hpae139
Published: 01 November 2024
Journal Article
Traditional Chinese medicine: cardiovascular drug development through a holistic framework
European Heart Journal, Volume 45, Issue 40, 21 October 2024, Pages 4315–4317, https://doi.org/10.1093/eurheartj/ehae625
Published: 17 September 2024
Journal Article
EDITOR'S CHOICE
Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction
European Heart Journal, Volume 45, Issue 25, 1 July 2024, Pages 2186–2196, https://doi.org/10.1093/eurheartj/ehae300
Published: 28 May 2024
Journal Article
Identification of three mechanistic pathways for iron-deficient heart failure
European Heart Journal, Volume 45, Issue 26, 7 July 2024, Pages 2281–2293, https://doi.org/10.1093/eurheartj/ehae284
Published: 11 May 2024
Journal Article
Acetazolamide for acute heart failure: is ADVOR a riddle wrapped in a mystery inside an enigma?
European Heart Journal, Volume 44, Issue 37, 1 October 2023, Pages 3683–3685, https://doi.org/10.1093/eurheartj/ehad560
Published: 25 August 2023
Journal Article
Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure
The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 1, January 2024, Pages 4–9, https://doi.org/10.1210/clinem/dgad398
Published: 06 July 2023
Journal Article
Stroke in patients with heart failure and reduced or preserved ejection fraction
European Heart Journal, Volume 44, Issue 31, 14 August 2023, Pages 2998–3013, https://doi.org/10.1093/eurheartj/ehad338
Published: 26 June 2023
Journal Article
Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium–glucose cotransporter 2 inhibitors
European Heart Journal, Volume 44, Issue 48, 21 December 2023, Pages 5027–5035, https://doi.org/10.1093/eurheartj/ehad235
Published: 22 April 2023
Journal Article
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2202–2212, https://doi.org/10.1093/eurheartj/ehad210
Published: 13 April 2023
Journal Article
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox
European Heart Journal, Volume 44, Issue 13, 1 April 2023, Pages 1136–1153, https://doi.org/10.1093/eurheartj/ehad083
Published: 22 March 2023
Journal Article
Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure?
European Heart Journal, Volume 44, Issue 17, 1 May 2023, Pages 1522–1525, https://doi.org/10.1093/eurheartj/ehad158
Published: 21 March 2023
Journal Article
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction
European Heart Journal, Volume 44, Issue 8, 21 February 2023, Pages 668–677, https://doi.org/10.1093/eurheartj/ehac801
Published: 12 January 2023
Journal Article
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
European Heart Journal, Volume 44, Issue 5, 1 February 2023, Pages 396–407, https://doi.org/10.1093/eurheartj/ehac693
Published: 07 December 2022
Journal Article
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4469–4479, https://doi.org/10.1093/eurheartj/ehac487
Published: 26 August 2022
